Article
Exome sequencing for bipolar disorder points to roles of de novo loss-of-function and protein-altering mutations.
Molecular psychiatry - 1 Jul 2016
Kataoka M, Matoba N, Sawada T, Kazuno A-A, Ishiwata M, Fujii K, Matsuo K, Takata A, Kato T
Abstract excerpt
Although numerous genetic studies have been conducted for bipolar disorder (BD), its genetic architecture remains elusive. Here we perform, to the best of our knowledge, the first trio-based exome sequencing study for BD to investigate potential roles of de novo mutations in the disease etiology. We identified 71 de novo point mutations and one de novo copy-number mutation in 79 BD probands. Among the genes hit...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
